Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.52 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | QPCT | Q16769 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2226834 | 0.86 | APLNR (0.63) | APLNRALDH1A1SMN1; SMN2TDP1TAS1R3 | |
| SCHEMBL20496920 | 0.84 | APLNR (0.61) | APLNRALDH1A1SMN1; SMN2TDP1TAS1R3 | |
| SCHEMBL25647860 | 0.84 | APLNR (0.65) | APLNRALDH1A1TAS1R3TAS1R1TSHR | |
| SCHEMBL10141758 | 0.84 | APLNR (0.65) | APLNRALDH1A1TAS1R3TAS1R1TSHR | |
| SCHEMBL18415441 | 0.82 | TAS1R3 (0.67) | APLNRALDH1A1TAS1R3TAS1R1TSHR | |
| SCHEMBL933063 | 0.81 | APLNR (0.76) | APLNRALDH1A1TAS1R3TAS1R1TSHR | |
| SCHEMBL4739573 | 0.81 | APLNR (0.56) | APLNRALDH1A1SMN1; SMN2TDP1TAS1R3 | |
| SCHEMBL2261220 | 0.81 | APLNR (0.65) | APLNRALDH1A1TAS1R3TAS1R1TSHR | |
| SCHEMBL29209631 | 0.80 | APLNR (0.59) | APLNRALDH1A1TAS1R3TAS1R1TSHR | |
| SCHEMBL4739043 | 0.80 | APLNR (0.55) | APLNRALDH1A1SMN1; SMN2TDP1TAS1R3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11766435-B2 | N3-substituted iminopyrimidinones as antimalarial agents | MERCK SHARP & DOHME LLC (US) | 2023-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11766435-B2 | N3-substituted iminopyrimidinones as antimalarial agents | CTSL, ANPEP, PRSS1 | APLNR 710/4885ALDH1A1 2013/4885SMN1; SMN2 3149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.